Several studies reported subsequent leukemias, particularly acute myelogenous leukemia (AML) associated with translocations of the MLL gene at chromosomal band 11q23 when etoposide or other topoisomerase II inhibitors (topo II i) were used in therapy of primary cancer [56,57,58]. Here, KMT2A is linked to acute myeloid leukemia.